PLOS Medicine

2004 - 2022

From Public Library of Science
Bibliographic data for series maintained by plosmedicine ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 2, issue 12, 2005

Local Literature Bias in Genetic Epidemiology: An Empirical Evaluation of the Chinese Literature pp. 1-

Zhenglun Pan, Thomas A Trikalinos, Fotini K Kavvoura, Joseph Lau and John PA Ioannidis

Adherence to Antiretroviral Therapy: Merging the Clinical and Social Course of AIDS pp. 1-

Arachu Castro

Genetic Prediction of Future Type 2 Diabetes pp. 1-

Valeriya Lyssenko, Peter Almgren, Dragi Anevski, Marju Orho-Melander, Marketa Sjögren, Carola Saloranta, Tiinamaija Tuomi, Leif Groop and the Botnia Study Group

Moral Imagination: The Missing Component in Global Health pp. 1-

Solomon R Benatar

Selection Bias in Meta-Analyses of Gene-Disease Associations pp. 1-

Jin Ling Tang

Correction/Clarification about FDA Review Documents pp. 1-

Erick Turner

Editor's Reply pp. 1-

Emma Veitch

Volume 2, issue 11, 2005

Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial pp. 1-

Bertran Auvert, Dirk Taljaard, Emmanuel Lagarde, Joëlle Sobngwi-Tambekou, Rémi Sitta and Adrian Puren

Rationing Antiretroviral Therapy for HIV/AIDS in Africa: Choices and Consequences pp. 1-

Sydney Rosen, Ian Sanne, Alizanne Collier and Jonathon L Simon

Why Medical Students Are Crucial to the Future of Research in South Asia pp. 1-

Fawad Aslam, Murtaza Shakir and Muhammad Ahad Qayyum

“Rapid-Impact Interventions”: How a Policy of Integrated Control for Africa's Neglected Tropical Diseases Could Benefit the Poor pp. 1-

David H Molyneux, Peter J Hotez and Alan Fenwick

Beyond Trial Registration: A Global Trial Bank for Clinical Trial Reporting pp. 1-

Ida Sim and Don E Detmer

Clinical Trial Registration: The Differing Views of Industry, the WHO, and the Ottawa Group pp. 1-

Karmela Krleža-Jerić

Response to Amir Attaran pp. 1-

John McArthur, Jeffrey D Sachs and Guido Schmidt-Traub

Power, Reliability, and Heterogeneous Results pp. 1-

Ian Shrier

The Clinical Interpretation of Research pp. 1-

Stephen G Pauker

Mental Health Care and Mental Health Legislation in Pakistan: No Mercy for Losers pp. 1-

Haider Ali Naqvi

Author's Reply pp. 1-

Amir Attaran

Volume 2, issue 10, 2005

Data Cleaning: Detecting, Diagnosing, and Editing Data Abnormalities pp. 1-

Jan Van den Broeck, Solveig Argeseanu Cunningham, Roger Eeckels and Kobus Herbst

Making Practical Markets for Vaccines pp. 1-

Donald W Light

Achieving the Millennium Development Goals: Does Mental Health Play a Role? pp. 1-

J Jaime Miranda and Vikram Patel

An Immeasurable Crisis? A Criticism of the Millennium Development Goals and Why They Cannot Be Measured pp. 1-

Amir Attaran

Use of Preclinical Models to Improve Treatment of Retinoblastoma pp. 1-

Michael A Dyer, Carlos Rodriguez-Galindo and Matthew W Wilson

We Must Find the Problem in the Intrinsic Mechanisms of Both Media and Medical Research pp. 1-

Luciano Benedetti

Tackling Publication Bias in Clinical Trial Reporting pp. 1-

Emma Veitch and The PLoS Medicine Editors

Volume 2, issue 9, 2005

Curbing the Influence of the Drug Industry: A British View pp. 1-

Richard Smith

The European Rare Diseases Therapeutic Initiative pp. 1-

Alain Fischer, Pascale Borensztein and Claire Roussel

What Can We Do to Improve Child Health in Southern Italy? pp. 1-

Maurizio Bonati and Rita Campi

Predicting Cesarean Section and Uterine Rupture among Women Attempting Vaginal Birth after Prior Cesarean Section pp. 1-

Gordon C S Smith, Ian White, Jill P Pell and Richard Dobbie

The Effect of Automated Alerts on Provider Ordering Behavior in an Outpatient Setting pp. 1-

Andrew W Steele, Sheri Eisert, Joel Witter, Pat Lyons, Michael A Jones, Patricia Gabow and Eduardo Ortiz

Deception in Research on the Placebo Effect pp. 1-

Franklin G Miller, David Wendler and Leora C Swartzman

Computerized Physician Order Entry Systems: The Coming of Age for Outpatient Medicine pp. 1-

Robert L Davis

Authors' Reply: Measurement Errors in Schizophrenia Epidemiology pp. 1-

John McGrath, Sukanta Saha, Joy Welham and David Charles Chant

Response to Stampfer Commentary pp. 1-

David F Williamson

A New Era of Hope for the World's Most Neglected Diseases pp. 1-

The PLoS Medicine Editors

Volume 2, issue 8, 2005

Why Most Published Research Findings Are False pp. 1-

John P A Ioannidis

The “Free by 5” Campaign for Universal, Free Antiretroviral Therapy pp. 1-

Alan Whiteside and Sabrina Lee

Human Dignity as a Criterion for Science Policy pp. 1-

Timothy Caulfield and Audrey Chapman

Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges pp. 1-

Roland R Regoes, Ira M Longini, Mark B Feinberg and Silvija I Staprans

The Discriminatory Attitudes of Health Workers against People Living with HIV pp. 1-

Gobopamang Letamo

Estimating the Number of Antiretroviral Treatment Facilities Based on the Wilson–Blower Method pp. 1-

Ntambwe Malangu

Minimizing Mistakes and Embracing Uncertainty pp. 1-

The PLoS Medicine Editors

Evidence-Based Medicine in Iberoamerica: Problems and Possible Solutions pp. 1-

Zulma Ortiz, Pablo Perel and Jordi Pardo

The Need for a New Specialist Professional Research System of “Pure” Medical Science pp. 1-

Bruce G Charlton and Peter Andras

Volume 2, issue 7, 2005

The Global Fight against the Stigma of Schizophrenia pp. 1-

Nadia Kadri and Norman Sartorius

Global Health Challenges: The Need for an Expanded Discourse on Bioethics pp. 1-

Solomon R Benatar, Abdallah S Daar and Peter A Singer

Lifetime Socioeconomic Position and Twins' Health: An Analysis of 308 Pairs of United States Women Twins pp. 1-

Nancy Krieger, Jarvis T Chen, Brent A Coull and Joe V Selby

Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review pp. 1-

Kathleen Hempenstall, Turo J Nurmikko, Robert W Johnson, Roger P A'Hern and Andrew SC Rice

Pathways to “Evidence-Informed” Policy and Practice: A Framework for Action pp. 1-

Shelley Bowen and Anthony B Zwi

Appropriate Models for the Management of Infectious Diseases pp. 1-

Helen J Wearing, Pejman Rohani and Matt J Keeling

Why PLoS Sponsored a Roundtable of Medical Whistleblowers pp. 1-

The PLoS Medicine Editors

What Can We Learn from Medical Whistleblowers? pp. 1-

Jeanne Lenzer

The Genetics of Schizophrenia pp. 1-

Patrick F Sullivan

What Are the Roles and Responsibilities of the Media in Disseminating Health Information? pp. 1-

Gary Schwitzer, Ganapati Mudur, David Henry, Amanda Wilson, Merrill Goozner, Maria Simbra, Melissa Sweet and Katherine A Baverstock

Medical Journals, Academia, and Industry-Sponsored Clinical Trials pp. 1-

Valeria Frighi

Bitter Pills and Puffed Trials pp. 1-

Stephen Senn

Might Banning Trial Publication Do More Harm Than Good? pp. 1-

David Sackett

Little Fish Are Less Likely to Take the Bait pp. 1-

Harvey Marcovitch

Focus on the Funding and Production of Evidence Rather Than Its Publication pp. 1-

Trevor Sheldon

Volume 2, issue 6, 2005

Medical Decision Making: The Family–Doctor–Patient Triad pp. 1-

Fawad Aslam, Omar Aftab and Naveed Z Janjua

Allocating Antiretrovirals in South Africa: Using Modeling to Determine Treatment Equity pp. 1-

David P Wilson and Sally M Blower

Vitamin C for Preventing and Treating the Common Cold pp. 1-

Robert M Douglas and Harri Hemilä

How the Cochrane Collaboration Is Responding to the Asian Tsunami pp. 1-

Prathap Tharyan, Mike Clarke and Sally Green

Meeting the Health Needs of Migrant Workers Affected by the Tsunami pp. 1-

David Wilson

Authors' Reply pp. 1-

Alexander M Capron and Andreas Reis

Author's Reply pp. 1-

Deborah Hayden

Call for Biohistory Guidelines pp. 1-

Jordan Paradise

Volume 2, issue 5, 2005

Why We Need to Rethink the Diseases of Affluence pp. 1-

Thomas E Novotny

Is Evidence-Based Medicine Relevant to the Developing World? pp. 1-

Paul Chinnock, Nandi Siegfried and Mike Clarke

Taking More Than a Fair Share? The Migration of Health Professionals from Poor to Rich Countries pp. 1-

Delanyo Dovlo

Unjustified Restrictions on Letters to the Editor pp. 1-

Douglas G Altman

Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development pp. 1-

Majid Ezzati, Stephen Vander Hoorn, Carlene M M Lawes, Rachel Leach, W Philip T James, Alan D Lopez, Anthony Rodgers and Christopher J L Murray

HIV Epidemiology in Africa: Weak Variables and Tendentiousness Generate Wobbly Conclusions pp. 1-

Stuart Brody and John J Potterat

Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies pp. 1-

Richard Smith

A Systematic Review of the Prevalence of Schizophrenia pp. 1-

Sukanta Saha, David Chant, Joy Welham and John McGrath

Fundamental Limits to the Precision of Early Warning Systems for Epidemics of Infectious Diseases pp. 1-

John M Drake

Authors' Reply: Don't Let the Hypothesis Slip pp. 1-

Ben A Lopman, Geoff P Garnett, Simon Gregson, Simon Gregson and Peter R Mason

The Global Prevalence of Schizophrenia pp. 1-

Dinesh Bhugra

Editors' Reply pp. 1-

Virginia Barbour, Barbara Cohen and Gavin Yamey

Meeting the Needs of Different Research Communities pp. 1-

The PLoS Medicine Editors

Volume 2, issue 4, 2005

telederm.org: Freely Available Online Consultations in Dermatology pp. 1-

H Peter Soyer, Rainer Hofmann-Wellenhof, Cesare Massone, Gerald Gabler, Huiting Dong, Fezal Ozdemir and Giuseppe Argenziano

Integrating Equity into Health Information Systems: A Human Rights Approach to Health and Information pp. 1-

Lexi Bambas

Nonstationary Influence of El Niño on the Synchronous Dengue Epidemics in Thailand pp. 1-

Bernard Cazelles, Mario Chavez, Anthony J McMichael and Simon Hales

The Problem with Academic Medicine: Engineering Our Way into and out of the Mess pp. 1-

Jonathan Rees

Volume 2, issue 3, 2005

Hookworm: “The Great Infection of Mankind” pp. 1-

Peter J Hotez, Jeff Bethony, Maria Elena Bottazzi, Simon Brooker and Paulo Buss

Designing an Equitable Strategy for Allocating Antiretroviral Treatments pp. 1-

Alexander M Capron and Andreas Reis

Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis pp. 1-

Jeremy G Wheeler, Kelsey D M Juzwishin, Gudny Eiriksdottir, Vilmundur Gudnason and John Danesh

A Canadian Perspective pp. 1-

James E Till

Statement of Principles for Health Care Journalists pp. 1-

Gary Schwitzer

Author's Reply pp. 1-

Margaret Gatz

How Does PLoS Medicine Manage Competing Interests? pp. 1-

The PLoS Medicine Editors

Volume 2, issue 2, 2005

The Courage to Change the Rules: A Proposal for an Essential Health R&D Treaty pp. 1-

Nicoletta Dentico and Nathan Ford

Scaling Up AIDS Treatment: What Is the Potential Impact and What Are the Risks? pp. 1-

Peter Lamptey and David Wilson

Can Routine Commercial Cord Blood Banking Be Scientifically and Ethically Justified? pp. 1-

Nicholas M Fisk, Irene A G Roberts, Roger Markwald and Vladimir Mironov

Free Community Science and the Free Development of Science pp. 1-

Richard Stallman

Open Access to Trials Register pp. 1-

Susanne McCabe

Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries pp. 1-

David P Wilson and Sally M Blower

Why Bigger Is Not Yet Better: The Problems with Huge Datasets pp. 1-

The PLoS Medicine Editors

Volume 2, issue 1, 2005

Deadly Alliances: Death, Disease, and the Global Politics of Public Health pp. 1-

Matthew Gandy

Trade and Health: Is the Health Community Ready for Action? pp. 1-

Kelley Lee and Meri Koivusalo

Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology? pp. 1-

Ross McKinney and David Korn